Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/17/2010US7776924 for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjunction with nitroreductase enzymes as hypoxia selective cytotoxins and as anticarcinogenic agents; 2((2-Bromoethyl)-2-{[(2-hydroxyethyl)amino]carbonyl}-4,6-dinitroanilino)ethyl methanesulfonate
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776908 Use in inhibiting PI-3-kinase activity in mammals; cancer; Acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta , 12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ]phenanthren-11-yl ester
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776869 protein kinase modulators such as 3-((2-amino-5-pyrimidinyl)ethynyl)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide, useful for the prophylaxis and treatment of inflammation, cancer, rheumatoid arthritis and for reducing blood flow in tumors
08/17/2010US7776867 Furanopyrimidines
08/17/2010US7776865 checkpoint kinase inhibitors; for treating and preventing proliferative diseases such as cancer, inflammation and arthritis, neurodegenerative diseases such Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
08/17/2010US7776849 used as heat shock protein 90 inhibitors, for the preventing and/or treating for cancer and chronic myelocytic leukemia; antitumor agent; angiogenesis inhibitors; anticarcinorgenic agents
08/17/2010US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin
08/17/2010US7776541 Psoriasin expression by breast epithelial cells
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776519 detection of mesenchymal tumoral cells by using the Slug (zinc fingers domains) gene; biomarker
08/17/2010US7776369 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis
08/17/2010US7776343 comprising a negatively charged organic carrier and a positively charged antigen; for facilitating the induction of a cytotoxic T-lymphocyte response to an antigen
08/17/2010US7776342 Preparations that potentiate immunogenicity in low immunogenic antigens
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2605854C Novel pyridine derivative and pyrimidine derivative (3)
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
08/17/2010CA2527203C Casr antagonist
08/17/2010CA2456453C Cc-1065 analog synthesis
08/17/2010CA2444867C Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2403086C Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2364314C Non-squamous epithelium-specific transcription
08/17/2010CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals
08/17/2010CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2269634C Reagents and methods useful for detecting diseases of the breast
08/17/2010CA2224153C Radiolabeled peptide compositions for site-specific targeting
08/17/2010CA2169260C Gene therapy for solid tumors, papillomas and warts
08/17/2010CA2144527C Up-converting reporters for biological and other assays using laser excitation techniques
08/12/2010WO2010091386A2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010WO2010091382A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010WO2010091306A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
08/12/2010WO2010091303A1 Novel steroidal cyp17 inhibitors/antiandrogens
08/12/2010WO2010091299A2 Novel combination cancer therapies
08/12/2010WO2010091198A1 Therapeutic compositions comprising monoterpenes
08/12/2010WO2010091193A2 Triptolide c-ring derivatives as anticancer agents and immune modulators
08/12/2010WO2010091192A2 Nanoscale platinum compounds and methods of use thereof
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010090764A1 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010WO2010090498A2 Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function
08/12/2010WO2010090290A1 Aminopyrazine derivative and medicine
08/12/2010WO2010090234A1 12-deoxyfusicoccin sugar chain-modified derivatives and uses thereof
08/12/2010WO2010090222A1 Hb-egf-bound protein complex
08/12/2010WO2010090040A1 Monoclonal antibodies that recognize cholangiocarcinoma-specific sugar chain epitopes
08/12/2010WO2010089782A1 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
08/12/2010WO2010089752A1 Carjbamoylphosphonates as inhibitors and uses thereof
08/12/2010WO2010089580A1 Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4
08/12/2010WO2010089559A1 Cancer diagnosis and treatment
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010089509A1 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089508A1 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089507A1 Derivatives of 6-(6-o-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089506A1 Derivatives of 6-(6-o-cycloalkyl or 6-nh-cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
08/12/2010WO2010089379A1 Method and means for producing tissues and tissues obtained
08/12/2010WO2010089355A1 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
08/12/2010WO2010089327A2 Indole derivatives as anticancer agents
08/12/2010WO2010089064A1 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
08/12/2010WO2010089019A1 Compounds comprising n-formyl-methionine residues and tumor-targeting peptides
08/12/2010WO2010088924A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/12/2010WO2010088842A1 Pharmaceutical compositions containing pyridyl cyanoguanidines, preparation methods and uses thereof
08/12/2010WO2010088739A1 Sam-6 variants, target and methods of use
08/12/2010WO2010061142A3 Composition containing an angiotensin ii at2 receptor antagonist, intended for slowing cancer cell tumor initiation in a high-risk mammal
08/12/2010WO2010054126A3 Small molecule modulators of epigenetic regulation and their therapeutic applications
08/12/2010WO2010045896A3 Polymeric composition with synergistic effect in treatment of tumour diseases
08/12/2010WO2010045199A3 Method of modulating ship activity
08/12/2010WO2010042758A3 Oxazole-pyridazine-oxazole alpha-helix mimetic
08/12/2010WO2010042685A3 Inhibitors of the atb(0,+) transporter and uses thereof
08/12/2010WO2010042489A3 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/12/2010WO2010019954A9 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
08/12/2010WO2010019257A3 Prodrug activation in cancer cells using molecular switches
08/12/2010WO2009108360A3 Inhibition of post-radiation tumor growth by an inhibitor of vasculogenesis
08/12/2010US20100204469 Conjugated psychotropic drugs and uses thereof
08/12/2010US20100204458 Process for the Production of Immunogenic Compositions
08/12/2010US20100204338 Anti-angiogenic agents and methods of use
08/12/2010US20100204327 Methods for making retinoids and uses thereof
08/12/2010US20100204326 Novel agents for treatment of ailments and dysfunctions
08/12/2010US20100204312 Methods and compositions for treating cancer
08/12/2010US20100204308 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy
08/12/2010US20100204305 Small interfering rna molecules against ribonucleotide reductase and uses thereof
08/12/2010US20100204298 Use of Antisense Oligonucleotides Against CPLA2 in the Treatment of Cancer
08/12/2010US20100204286 Method for reducing gastrointestinal adverse effects of cytotoxic agents
08/12/2010US20100204276 Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/12/2010US20100204263 Method of treating multidrug resistant cancers
08/12/2010US20100204262 Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
08/12/2010US20100204261 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
08/12/2010US20100204260 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
08/12/2010US20100204257 Spiroindolinone pyridine derivatives
08/12/2010US20100204246 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer
08/12/2010US20100204238 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
08/12/2010US20100204235 Organic compounds
08/12/2010US20100204234 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases
08/12/2010US20100204231 Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancer
08/12/2010US20100204228 Aryl Sulfonamides Useful for Modulation of the Progesterone Receptor
1 ... 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 ... 2211